TEV-56248
FpA-AS-30094
Phase 3 small_molecule active
Quick answer
TEV-56248 for Asthma is a Phase 3 program (small_molecule) at Teva Generics B.V with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Generics B.V
- Indication
- Asthma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active